Navigation Links
MonoSol Rx Completes Thin Film Ondansetron Pilot Bioequivalence Study
Date:2/21/2008

other delivery forms including competing film products. MonoSol Rx's intellectual property includes thin film producing polymers, drug taste masking, processes that ensure product and content uniformity at scale, novel packaging and in-process testing methods.

Mr. Schobel continued, "The strength of our pipeline and intellectually property, combined with the convenience and potential dosing benefits of our thin film technology, sets MonoSol Rx apart as an innovator in the drug delivery sector. As the pharmaceutical industry evolves and more blockbuster drugs transition to generic, MonoSol Rx's objective is to leverage our thin film technology via partnerships and self-funded development initiatives to bring new products to market that enhance the effectiveness and market-appeal of already-approved compounds. We believe this strategy will enable MonoSol Rx to cement its leadership position in the thin film drug delivery market."

MonoSol Rx has signed a term sheet and is in final negotiations with a partner to market its thin film formulations for ondansetron in 4 and 8 mg strengths. Negotiations are expected to conclude prior to global regulatory submissions.

Keith Kendall, chief financial officer for MonoSol Rx, commented, "Completing an agreement with a partner for our ondansetron formulation should further solidify the market potential of MonoSol Rx's technology and continue to demonstrate our ability to develop and manufacture prescription thin film products at scale for our partners. This agreement would build upon the development and supply agreement that we signed with Adams Respiratory Therapeutics in March 2007 for another, as-yet-unnamed prescription product."

With an annual prescription market of $1.2 billion in the US and approx $100 million in the top-five European countries, ondansetron is recognized as the leading 5-HT3 antagonist used in the prevention and treatment of nausea and vomiting.

About MonoSol Rx

Mo
'/>"/>

SOURCE MonoSol Rx
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
7. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
8. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
9. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
10. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... , July 6, 2015 E-QURE Corp (OTCQB: ... present live at VirtualInvestorConferences.com on July 9, 2015. ... http://tinyurl.com/e-qure-presentation This will be ... to ask the company questions in real-time - both ... "virtual trade booth." If attendees are not able to ...
(Date:7/6/2015)... MORRISTOWN, N.J. , July 6, 2015 /PRNewswire/ ... focused on developing novel therapeutics that target inflammation ... Bill Bradford , M.D., PhD, as Chief Medical ... the company,s clinical development strategy and programs, which ... and other inflammatory and fibrotic conditions.  Bill is ...
(Date:7/6/2015)... July 6, 2015  Impax Laboratories, Inc. (NASDAQ: ... Ph.D. has resigned from the Company,s Board of Directors ... was a co-founder of Impax in 1995 and served ... October 2006 until April 2014. Logo - ... Impax,s President and Chief Executive Officer stated, "We wish ...
Breaking Medicine Technology:E-QURE Corp to Webcast, Live, at VirtualInvestorConferences.com July 9 2Moerae Matrix, Inc. (Moerae) Appoints Bill Bradford, M.D., PhD, as Chief Medical Officer 2Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 2Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 3Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 4Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 5
... Berg Pharma, a Boston based pharmaceutical company presented novel ... metabolism at the 103rd Annual AACR meeting.  The company ... that dealt with endothelial cell biology relative to tumor ... cancer therapy, synergy of BPM 31510, Berg,s lead oncology ...
... April 4, 2012 Zimmer Holdings, Inc. (NYSE: ... sales and earnings conference call will be broadcast live over ... Eastern Time.  A news release detailing the quarterly results will ... of the conference call. The live audio ...
Cached Medicine Technology:Berg Pharma Presents Key Findings in Cancer Systems Biology and Mitochondrial Metabolism at AACR Meeting 2Berg Pharma Presents Key Findings in Cancer Systems Biology and Mitochondrial Metabolism at AACR Meeting 3Zimmer Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2012 Results 2
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... The Path ... look into the economic transformation associated with the U.S. economy over the past 40 ... associated with its use. In many ways, the book is a time capsule that ...
(Date:7/5/2015)... ... July 05, 2015 , ... Women's Excellence in Wellness, powered ... These classes are geared towards families that want their children to stay active ... , The fitness class will take place TUESDAYS at 4:30pm. Questions? Call 248-601-6683. ...
(Date:7/5/2015)... ... July 05, 2015 , ... Doctors at the Swedish Cancer Institute in ... one day change the outlook for people with pleural mesothelioma. Surviving Mesothelioma has just ... Researchers report that five mesothelioma patients treated with 25Gy of radiation over five days ...
(Date:7/4/2015)... ... ... Chronic Neck Pain. Neck pain is no small problem. NIH ... Another 19% suffer from head, migraine, or facial pain, in some cases related to ... workers must deal with neck pain. Strategies for mitigating neck pain range ...
(Date:7/3/2015)... ... ... Harvest Hope Food Bank will hopefully be getting a large donation of canned food ... of Greenville SC are making it their mission to collect as many canned items as ... donations from the public as well. As part of the canned food drive, these local ...
Breaking Medicine News(10 mins):Health News:New Book Brings Reveals The Repercussions Associated With The Global Economy 2Health News:New Mesothelioma Study Calls IMRT/Surgery Combo “Innovative and Promising”, According to Surviving Mesothelioma 2Health News:New Advancement in Treatment of Chronic Neck Pain 2Health News:New Advancement in Treatment of Chronic Neck Pain 3Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 3
... Blue Cross and Blue Shield of Georgia (BCBSGA) announced today ... H1N1 (swine flu) vaccine when it becomes commercially available to ... members whose benefit plans provide coverage for vaccines. , ... flu vaccine administration for those whose health plans offer vaccine ...
... Scientists at Leeds and Bradford have discovered a unique ,DNA ... that unlocks an egg,s fertility and triggers new life. ... of Leeds, in collaboration with Dr Martin Brinkworth at the ... signature that can only be recognised by an egg from ...
... , , ANAHEIM, Calif., Aug. ... advanced entertainment and digital display technology options, LG Electronics has ... patient rooms - with its new "HealthView"(TM) series ... For patients, families and doctors alike, HealthView and other ...
... SILVER SPRING, Md., Aug. 3 Four simple questions ... ongoing couples therapy can greatly increase chances for reconciliation and ... clinical trial with couples to date, it shows that divorce ... were 46.2 percent less than that of couples who received ...
... , , PHOENIX, Aug. ... in stabilized rice bran (SRB), nutrient research and technology, today announced three ... the Company. , , Leo Gingras, Chief Operating Officer ... 2012. Gingras joined NutraCea in 2007 as COO, after 18 years ...
... , , ... Inc. ("Zogenix"), a privately held pharmaceutical company and Astellas ... agreement for Sumavel DosePro (sumatriptan injection) needle-free delivery system. ... and is a first-of-its-kind needle-free delivery system for subcutaneous ...
Cached Medicine News:Health News:BCBSGA Announces Decision to Cover H1N1 Vaccine Administration 2Health News:Unlocking the key to human fertility 2Health News:Unlocking the key to human fertility 3Health News:LG Electronics Introduces New Flat-Panel HDTVs Designed Specifically for Long-Term Care Facilities 2Health News:LG Electronics Introduces New Flat-Panel HDTVs Designed Specifically for Long-Term Care Facilities 3Health News:LG Electronics Introduces New Flat-Panel HDTVs Designed Specifically for Long-Term Care Facilities 4Health News:Therapy Technique Cuts Divorce/Separation Rate By Nearly 50 Percent 2Health News:NutraCea Announces Additions to Management Team; Chief Operating Officer Extends Employment Contract 2Health News:NutraCea Announces Additions to Management Team; Chief Operating Officer Extends Employment Contract 3Health News:NutraCea Announces Additions to Management Team; Chief Operating Officer Extends Employment Contract 4Health News:Zogenix and Astellas Enter Exclusive Co-Promotion Agreement in the US for Newly Approved Sumavel(TM) DosePro(TM) 2Health News:Zogenix and Astellas Enter Exclusive Co-Promotion Agreement in the US for Newly Approved Sumavel(TM) DosePro(TM) 3Health News:Zogenix and Astellas Enter Exclusive Co-Promotion Agreement in the US for Newly Approved Sumavel(TM) DosePro(TM) 4
... Used for catheter positioning and exchange in ... the wire guide coils allows utilization of ... smooth transition to a very flexible tip. ... is the most rigid coiled wire guide ...
Supplied sterile in peel-open packages. Intended for one-time use....
... Used as an initial access wire into ... prior to an endourology procedure. The mandril type ... that of a .035 inch (0.89 mm) diameter ... guide is of spring coil construction over the ...
Used for percutaneous nephrostomy. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: